Intravitreal bromfenac liposomal suspension (100 μg / 0.1 ml). A safety study in rabbit eyes.
Sign Up to like & getrecommendations! Published in 2020 at "Experimental eye research"
DOI: 10.1016/j.exer.2020.108020
Abstract: INTRODUCTION There is a need to find alternative treatments for DME. Bromfenac has shown promise in inhibiting the COX-2 enzymatic pathway that partially causes the inflammatory cascade which contributes to the precipitation of DME. However,… read more here.
Keywords: intravitreal bromfenac; suspension 100; rabbit eyes; safety ... See more keywords